Solo educación · requiere revisión profesional
Research pathway · 08
Menopause & perimenopause, explained
The largest group of people researching hormones and "longevity" are women in perimenopause and menopause — and the honest answer is that the best-evidenced options here are approved medicines, not peptides. This page sorts it out.
Gratis · unos 10 minutos · revisado por un médico con licencia
Lo que la gente suele preguntar
The questions are practical: hot flushes, sleep, mood, weight change, libido, joint aches, brain fog. Many of these overlap with thyroid problems, iron deficiency and depression, which is why a provider tests before treating.
This pathway covers approved hormone therapy, the compounded alternatives that are marketed heavily, the non-hormonal options, and the peptide claims — with the evidence status on each.
Péptidos tratados en este contexto
Listados con fines educativos. Su inclusión no es una recomendación y ninguno es un tratamiento aprobado por la FDA para la cuestión anterior.
Menopausal hormone therapy (oestrogen & progesterone)
Menopausal hormone therapy
FDA-approved products · strongest evidence for symptoms
Leer la página → 02Hormone pellet therapy
Compounded pellets
Not FDA-approved · society statements caution
Leer la página → 03Thyroid basics
Thyroid
Approved treatment · rule out first
Leer la página → 04DHEA
DHEA / prasterone
Supplement · one approved prescription form
Leer la página → 05Testosterone therapy
Testosterone in women
Off-label · limited evidence (see page)
Leer la página → 06Semaglutide
GLP-1 medicines
FDA-approved for weight management
Leer la página → 07Kisspeptin
Kisspeptin research
Human physiology studies · not approved
Leer la página →Dónde está la evidencia
Hormone therapy has large randomised trials and decades of follow-up; for suitable women under 60 or within ten years of menopause, professional societies describe benefits as outweighing risks. Non-hormonal options — SSRIs/SNRIs, gabapentin, fezolinetant (approved 2023) — have controlled trials for hot flushes. Compounded pellets and "bioidentical" blends lack that evidence. Peptides have none for menopause.
El estado refleja únicamente el contexto de la investigación publicada y no constituye una afirmación de seguridad, eficacia o idoneidad para ninguna persona.
Preguntas que vale la pena llevar al profesional
La evaluación es el lugar para las preguntas individuales. Estas suelen hacer que esa conversación sea útil.
- Are my symptoms menopausal, thyroid-related, or something else — and what test tells us?
- Am I a candidate for approved hormone therapy, and which route (patch, gel, oral, local)?
- Is anything in my history — clots, breast cancer, migraine with aura — a contraindication?
- Which of the non-hormonal options have real evidence for hot flushes and sleep?
- What would make you say no?
Qué ocurre si empiezas una evaluación
The intake asks about your cycle history, symptoms, family history, clotting and cancer history, and current medicines. A licensed provider reviews it and tells you whether hormone therapy, non-hormonal options, testing, or a referral is the right next step. Free, about 10 minutes, no obligation.
Preguntas frecuentes
Is there a peptide for menopause?
No. No peptide has evidence for menopausal symptoms. Approved hormone therapy and several non-hormonal medicines do. Peptide marketing aimed at menopause should be treated with caution.
Are bioidentical hormones safer?
FDA-approved products include bioidentical oestradiol and progesterone. Compounded versions are not safer and are less consistently dosed.
Does this page recommend hormone therapy?
No. It explains what is approved and where evidence stands; whether it is appropriate for you is a provider's decision after intake.
Siguiente paso
Siguiente paso: una consulta confidencial de 3 minutos, revisada por un profesional con licencia. No se promete ni se da a entender ningún tratamiento.
Gratis · unos 10 minutos · revisado por un médico con licencia
Educación general · No es consejo médico · Se requiere aprobación profesional